Sensormedics Oxyshuttle
510(k) K862617
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK862617 | Date26 Sep 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Sensormedics Oxyshuttle(Tm)
- 510(k) Number
- FDA Product Code
- DQA
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2700
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Sensormedics Oxyshuttle is a Class 2 anesthesiology device designed for use in clinical settings to assist with patient monitoring during anesthesia. It functions as a pulse oximetry system, providing continuous measurement of oxygen saturation and related parameters.
The device was cleared by the FDA through a traditional 510(k) submission (K862617) on 26 September 1986, with product code DQA and advisory committee classification in cardiovascular. It is supplied by Sensor Medics Corp. and is identified as a single‑use, non‑reusable system; no specific sterility or MRI safety information is provided in the source data.
Other devices from Sensor Medics Corp.
Questions
AI-generated answers, 22 Sep 2026
What clinical purpose does the Sensormedics Oxyshuttle serve?
The Oxyshuttle is a Class 2 anesthesiology device that provides continuous pulse oximetry, measuring a patient’s oxygen saturation and related parameters throughout the anesthesia period to help clinicians maintain adequate oxygenation.
Is the Oxyshuttle intended for single‑use or multiple uses?
It is supplied as a single‑use, non‑reusable system. This design eliminates the need for reprocessing and helps ensure consistent performance for each patient.
How is the Oxyshuttle packaged and what storage considerations apply?
The device is provided by Sensor Medics Corp. as a ready‑to‑use unit. While the source data does not specify sterility or MRI safety, standard practice is to store single‑use monitoring equipment in a clean, dry environment until needed.
Through which regulatory pathway was the Oxyshuttle cleared?
The Oxyshuttle received FDA clearance via a traditional 510(k) submission (K862617) on 26 September 1986, demonstrating substantial equivalence to a predicate device and meeting the requirements for Class 2 cardiovascular monitoring devices.